BackLilly(Eli) Overview
Lilly(Eli) & Co

Lilly(Eli) Target Price

See Lilly(Eli)'s analyst price targets ($1.3K) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1,142.85

Average Target Price

$1331.3716.5% upside

19 analysts in the last 4 months

High: $1500 | Low: $940

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-18GuggenheimSeamus Fernandez$1,28412.4% upsideOpen
2026-09-15Berenberg BankKerry Holford$1,40022.5% upsideOpen
2026-09-10HSBC$94017.7% downsideOpen
2026-08-07UBS$1,37620.4% upsideOpen
2026-08-06Morgan Stanley$1,41924.2% upsideOpen
2026-08-06Wells FargoMohit Bansal$1,33016.4% upsideOpen
2026-08-06Cantor Fitzgerald$1,41023.4% upsideOpen
2026-08-06BMO CapitalEvan Seigerman$1,40022.5% upsideOpen
2026-07-14Bernstein$1,38521.2% upsideOpen
2026-07-13UBS$1,42524.7% upsideOpen
2026-07-13Guggenheim$1,27311.4% upsideOpen
2026-07-09UBS$1,37019.9% upsideOpen
2026-07-08Morgan StanleyTerence Flynn$1,34717.9% upsideOpen
2026-07-08RBC Capital$1,50031.3% upsideOpen
2026-07-08Truist Financial$1,37019.9% upsideOpen
2026-07-06Cantor Fitzgerald$1,35018.1% upsideOpen
2026-06-25Leerink PartnersDavid Risinger$1,2327.8% upsideOpen
2026-06-22Berenberg BankKerry Holford$1,1350.7% downsideOpen
2026-06-09Jefferies$1,35018.1% upsideOpen
2026-05-26Leerink PartnersDavid Risinger$1,1192.1% downsideOpen
2026-05-26HSBC$1,2519.5% upsideOpen
2026-05-21Wolfe Research$1,35018.1% upsideOpen
2026-05-05BarclaysEmily Field$1,40022.5% upsideOpen
2026-05-01Cantor FitzgeraldCarter Gould$1,2307.6% upsideOpen
2026-05-01Morgan Stanley$1,34417.6% upsideOpen
2026-04-10Morgan Stanley$1,32716.1% upsideOpen
2026-03-13JefferiesAkash Tewari$1,30013.8% upsideOpen
2026-03-06Deutsche BankJames Shin$1,28512.4% upsideOpen
2026-03-05Morgan StanleyTerence Flynn$1,31314.9% upsideOpen
2026-02-24RBC CapitalTrung Huynh$1,2509.4% upsideOpen
2026-02-19Barclays$1,35018.1% upsideOpen
2026-02-10Loop Capital MarketsIlya Zubkov$1,2005% upsideOpen
2026-02-05Goldman Sachs$1,26010.3% upsideOpen
2026-02-05BMO CapitalEvan Seigerman$1,30013.8% upsideOpen
2026-02-05Truist Financial$1,28112.1% upsideOpen
2026-02-05Scotiabank$1,30013.8% upsideOpen
2026-02-05Wells FargoMohit Bansal$1,28012% upsideOpen
2026-01-20Guggenheim$1,1611.6% upsideOpen
2026-01-06UBSMichael Yee$1,2509.4% upsideOpen
2026-01-05Leerink PartnersDavid Risinger$1,2348% upsideOpen
2025-12-16DaiwaNarumi Nakagiri$1,2307.6% upsideOpen
2025-12-15Goldman Sachs$1,1450.2% upsideOpen
2025-12-10HSBC$1,0706.4% downsideOpen
2025-12-04BMO Capital$1,2005% upsideOpen
2025-12-03Guggenheim$1,1631.8% upsideOpen
2025-12-02BMO CapitalEvan Seigerman$1,1003.7% downsideOpen
2025-12-01National BankTim Anderson$1,28612.5% upsideOpen
2025-11-24Morgan StanleyTerence Flynn$1,29012.9% upsideOpen
2025-11-24Bernstein$1,30013.8% upsideOpen
2025-11-19Truist FinancialSrikripa Devarakonda$1,1823.4% upsideOpen

Lilly(Eli) (LLY) FAQ

As of the most recent data, LLY shows a target price of $1.3K. Scroll down for historical charts and peer comparison views.

If Lilly(Eli) moved to the average analyst target of $1.3K, shares would be roughly 16.5% higher than $1142.85. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Lilly(Eli)'s earnings trajectory.

Besides this target price page, Stockcircle has Lilly(Eli)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $1.3K) with ownership activity and broader fundamentals.

Lilly(Eli)'s target price is $1.3K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.